Seeking Alpha

Investorideas.com's  Instablog

Investorideas.com
Send Message
www.InvestorIdeas.com is a meeting place for investors and public companies in leading sectors. Find investing ideas, news and research for biotech stocks, tech and mobile stocks, mining stocks, oil and gas, water stocks, renewable energy, beverage stocks, defense stocks, nanotech and more on... More
My company:
Investor Ideas
My blog:
Investor Ideas Newswire
View Investorideas.com's Instablogs on:
  • Biotech News Alert: MANAGEMENT OF SUNSHINE BIOPHARMA (OTCQB: SBFM) ALARMED BY THE RECENT WORLD HEALTH ORGANIZATION REPORT THAT CANCER IS ON THE RISE

    Montreal, Quebec, Canada - March 31, 2014 (Investorideas.com Biotech Newswire) Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer has issued a response to the recently released reports by the World Health Organization and the Pancreatic Cancer Action Network.

    "We are very pleased with the progress we have made thus far in our efforts to re-domicile the Company in Canada," said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. "We are anxious to complete the re-domiciling process as we have attendant growth and financing opportunities that we believe are available to us once we have completed this action. This is important for the Company's business strategy overall and for our Adva-27a anticancer drug candidate as we advance towards clinical trials for multidrug resistant breast cancer and pancreatic cancer."

    According to "World Cancer Report 2014" issued in February by the World Health Organization, cancer is on the rise and has become a leading cause of death worldwide, accounting for 8.2 million deaths in 2012. Lung cancer accounted for 1.59 million deaths and breast cancer represented half a million deaths. The report also says that cancer cases are expected to rise significantly, "It is expected that annual cancer cases will rise from 14 million in 2012 to 22 million within the next two decades."

    Additionally the Pancreatic Cancer Action Network released a special report entitled "The Alarming Rise of Pancreatic Cancer Deaths in the United States: Why We Need to Stem the Tide Today". The report noted that "T(t)he alarming findings presented in the report include the fact that by the year 2020, and possibly as early as 2015, pancreatic cancer will move from the fourth leading cause of cancer death to the second leading cause of cancer death in the United States."

    "We are alarmed and impassioned by these trends to move vigorously ahead with our clinical development of Adva-27a for aggressive forms of cancer," said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. "The Company is planning a Phase I clinical trial of Adva-27a for pancreatic cancer in parallel to the Phase I clinical trial of Adva-27a for multidrug resistant breast cancer to be conducted at McGill University's Jewish General Hospital in Montreal (Canada)."

    Sunshine Biopharma recently reported that it has initiated the construction of mouse xenograft models for pancreatic cancer as part of the plans of positioning Adva-27a for clinical development for pancreatic cancer in parallel with multidrug resistant breast cancer. Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935.

    Safe Harbor Forward-Looking Statements

    To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

    For Additional Information Contact:

    Camille Sebaaly, CFO
    Sunshine Biopharma Inc.
    Direct Line: 514-814-0464
    camille.sebaaly@sunshinebiopharma.com

    www.sunshinebiopharma.com

    Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: SBFM has renewed effective December 3,2013 with Investorideas for six months of news publication and general public awareness of the company news and technologies and products in the biopharma markets ( one hundred thousand shares of 144 stock per 3 month period for a total of six months ) More disclaimer info: www.investorideas.com/About/Disclaimer.aspBC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

    Tags: SBFM, biotech, pharma
    Mar 31 12:01 PM | Link | Comment!
  • NXT-ID (OTCQB:NXTD) Tech News Alert: Witness The Evolution Of Smart: Press Conference And Launch Event For Wocket(TM), A Next Generation Smart Wallet, To Be Held In New York City, May 28th: Pre-Ordering Available Following Event

    SHELTON, CT - March 31, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometric authentication company focused on the growing m-commerce market, announces the first corporate launch event and press conference for its next generation smart wallet, Wocket™, designed to replace all the cards in your wallet. The event will take place in New York City on May 28th.

    The marketing event and press conference will give consumers and media a first-hand look at the Wocket™ Smart Wallet, the Wocket™ Card, its new logo and brand images, new consumer video and new packaging. Following the event, consumers will be able to pre-order Wocket™ online.

    First consumer videos will be released online mid- April, prior to the event .The location and time for the press conference and launch to be held in New York will be announced shortly in upcoming marketing press releases.

    Introducing Wocket™ will be Mr. Gino Pereira, Chief Executive Officer of NXT-ID, Inc., accompanied by David Tunnell, Chief Technology Officer and Advisory Board member, Mr. Lawrence Flanagan, the former Global Chief Marketing Officer of MasterCard. Mr. Flanagan managed a $1.5 billion budget, directed marketing strategies in more than 50 countries and helped launch the company's hugely successful, "Priceless" advertising campaign.

    In anticipation of the launch event and press conference, Mr. Pereira said, "Wocket™ is truly the evolution of smart devices for consumers that are concerned about security in the payment industry. I believe Wocket™ addresses security and convenience better than any of our competitors coming to market. There is growing demand and consumer interest for a product like this that protects privacy and prevents identity theft and there are a number of features that makes Wocket™ stand out from the crowd. Wocket™ is biometrically secure, so only you can access it with your own unique combination of voice, PIN or pattern; each time your card is used the information on your card is zeroed, so it is useless to someone else who tries to use it or steal it; Wocket™ can store up more than 10,000 cards so all the loyalty cards and gift cards that you have at home, and can never find when you need them, are now easily accessible. Most importantly Wocket™ is separate from your phone, so if your phone is stolen, lost or runs out of battery, you can still use Wocket™, with its full functionality, just as you would your wallet."

    "At a time when smartphones are stolen and hacked daily, consumers are concerned about storing all their payment information and identity on their phone. Wocket™ will evolve as the payment industry evolves. Wocket™ is just the beginning of our MobileBio™ suite of products that include technologies for data encryption to further reduce credit card fraud similar to that recently experienced by Target and other retailers. Future versions of Wocket™ will include a wider range of communication technologies, such as 4G and NFC, protected by our proprietary encryption technologies "

    He went on to say, "Our goal is to stay ahead of the curve by bringing consumers the smartest payment, authentication and identity security solutions possible. Ten years from now we want consumers to remember this launch and talk about the first generation Wocket™ they purchased. Wocket™ has the capability to change the way people make credit card transactions worldwide."

    Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.

    Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.

    The Wocket product FAQ is available to consumers and media at http://nxt-id.com/wocket-faq/

    Interested consumers can also sign up for product info and news alerts in anticipation of the product. http://www.thewocket.com/, http://www.wocketwallet.com/

    About NXT- ID Inc. - Mobile Security for a Mobile World

    NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/

    NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/

    Forward-Looking Statements for NXT-ID

    This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

    Contact:

    Investor Inquiries:
    Kirin Smith
    ProActive Capital Group
    Direct: 646 863 6519

    800 665-0411

    Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013 :Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous services

    More info: http://www.investorideas.com/About/Disclaimer.asp

    BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

     

    Mar 31 11:17 AM | Link | Comment!
  • Privacy VS. Security; The Challenge And The Opportunity - How Biometrics And Cybersecurity Are Changing The Future; (NASDAQ:APEI) (OTCQB:NXTD) (OTCBB:PSID) (OTCQB:VSYS) (OTCQB:IMSC)

    New York, NY - March 28, 2014 (investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense releases video and commentary from its recent Security and Defense Conference , GameChanging Technologies: The Face and Future of Security", held in New York on March 11, 2014.

    This panel of industry experts discusses the current state of the security and defense industry, and explores where it's headed in 2014 and beyond including authentication, biometrics, biodefense, cyber security.

    In regards to cyber, Roger Cressey a Partner with Liberty Group Ventures, LLC said." Here's the problem with cybersecurity; nobody knows what it is. It is all things to all people right now and you may have one specific slice of the cybersecurity pie but I can tell you the government is still trying to figure out what it is For example , the Department of Defense is going to request $5 Billion dollars for the next fiscal year budget and even they aren't sure where all that money is going to go , they just know they need to spend more.

    He went on to say later in the session, "In cyber, the technology is changing at light speed and the regulatory and legal construct is still stuck in a dial up environment. So we all need to remember that Washington and the even at the State level is way behind the curve in terms of what kind of regulatory and legal framework need to be in place to reflect this new reality."

    Scott Greiper, President and Founding Partner Secure Strategy Group notes , " everybody in cyber ; the user and the provider is playing defense. Nobody is playing offense. We are looking for companies with technologies that play offense ."

    He also said in terms of biometrics, it's all about identity management "We have moved from bring your own device to bring your own identity."

    In terms of opportunity he stated , "We prefer to work with small public companies because the results of our efforts and management's effort is visible every day and that's where you can get wealthy in this space; is in the small public market area."

    Janice Kephart, Founder and CEO of The Secure Identity and Biometrics Association (SIBA) told the audience , " What I think in 2014, is that this could be very much the year of biometric but much will depend on the education and the acceptance of both the public and private sector. "

    Panel:

    MODERATOR: ROGER CRESSEY, Liberty Group Ventures

    PANELISTS: SCOTT GREIPER, Secure Strategy Group; MARTY MARTIN, Crane & Crane Consulting; JANICE KEPHART, The Secure Identity and Biometrics Association (SIBA)

    Video: https://www.youtube.com/watch?v=shXCEWuo9oY

    Visit the conference page to learn more:

    http://www.investorideas.com/Conference

    See more speaker bios and PowerPoint presentations /disclaimers and disclosures and more

    http://www.investorideas.com/Conference/Speakers.asp

    Speaker Bios:

    Roger Cressey is a Partner with Liberty Group Ventures, LLC in Arlington VA, a risk and crisis management firm specializing in cyber security, campus security and sports security. He most recently served as a Senior Vice President at Booz Allen Hamilton, supporting the firm's cyber security practice in the Middle East. Prior to joining Booz Allen, he was President and Founder of Good Harbor Consulting LLC, a security and risk management consulting firm.

    Mr. Cressey's government service included senior cyber security and counterterrorism positions in the Clinton and Bush Administrations. At the White House, he served as Chief of Staff of the President's Critical Infrastructure Protection Board from November 2001 - September 2002. He also served as Deputy for Counterterrorism on the National Security Council staff from November 1999 to November 2001. He was responsible for the coordination and implementation of US counterterrorism policy and managed the US Government response to multiple terrorism incidents, including the Millennium terror alert, the USS COLE attack, and the September 11th attacks.

    From 2004 - 2013, he served as an on-air counterterrorism analyst with NBC News, appearing frequently on NBC Nightly News, The Today Show, MSNBC and CNBC.

    Prior to his White House service, Mr. Cressey served in the Department of Defense, where he worked on US defense strategy and the review of Pentagon war plans. From 1991-1995, he served in the Department of State working on Middle East security issues, including serving as a member of the US delegation to the multilateral track of the Arab-Israeli peace process talks.

    His overseas experience includes serving as a Pol-Mil officer with the US Embassy in Israel and with UN peacekeeping operations in Somalia and the former Yugoslavia. While in the former Yugoslavia, Cressey was part of a United Nations team that planned the successful capture of the first individual indicted for war crimes in Croatia. From 2001 - 2006, he taught a graduate course on U.S. counterterrorism policy at Georgetown University. He also served as a Fellow at the Center on Law and Security at New York University.

    He received his B.A. in Political Science from the University of Massachusetts at Lowell and an M.A. in Security Policy Studies from The George Washington University. Roger is the recipient of the State Department's Meritorious and Superior Honor Awards and the Defense Department's Exceptional Civilian Service Award.

    Scott Greiper, President and Founding Partner Secure Strategy Group

    Mr. Greiper is the President and Founding Partner of Secure Strategy Group. He has had a distinguished 15-year career in the security and defense technology sectors as both a research analyst and investment banker, and is known as a thought leader in the industry. Before forming Secure Strategy Group, he was a Managing Director at Legend Merchant Group and Head of the firm's Convergent Security Group, which provided capital, strategic advisory and M&A services to growth companies in the security and defense technology markets. Previously, Mr. Greiper was a Principal and Senior Analyst at C. E. Unterberg, Towbin, where he covered public companies in the Global Security industry and was consistently ranked as one of the top analysts in the sector. He has worked with a range of industry leaders and is a frequent guest speaker and moderator at conferences and seminars across the country. Mr. Greiper attended the Executive MBA program at Columbia University and holds a B. A. in Economics from The University of Chicago. He is a member of the FBI InfraGard program, BENS (Business Executives for National Security), ASIS (American Society for Industrial Security) and NYSSA (New York Society for Security Analysts).

    Janice Kephart, Founder and CEO of The Secure Identity and Biometrics Association (SIBA)

    Janice recently returned from a Special Counsel position with the Senate Judiciary Committee, where she was asked to testify and then return to staff to support the national, border and identity security aspects of the now Senate-passed immigration reform legislation. Ms. Kephart is an internationally recognized border and ID security expert, who served as counsel to the 9/11 Commission and was a key author of the Staff Monograph, 9/11 and Terrorist Travel as well as the immigration and identity security-related facts and recommendations in the 9/11 Commission Report.

    More info: http://www.sibassoc.org/#!aboutsiba/csgz

    Janice speaks regularly at conferences, to international media, publishes articles and opeds around the world, and has testified before Congress 16 times on issues of border and ID security.

    Marty Martin, CEO of Crane & Crane Consulting

    Marty Martin has an accomplished career which includes service with the CIA, NSA, and the U.S. Army. He has developed invaluable insight, managerial experience, and relationships across the U.S. Government and many foreign governments and intelligence services at the highest levels. He is the CEO of Crane & Crane Consulting, LLC where he leads the firm's expansion and growth. He previously served as a Senior Executive for the International Oil Trading Company (IOTC), a multi-billion dollar enterprise with activities in Iraq , Jordan , Libya , Russia and the Caribbean . He also played a central role in HBO's Manhunt, a 2013 Emmy awarding winning documentary. Mr. Martin's experience includes over 29 years of U.S. Government service including U.S. Special Forces, the National Security Agency, and the CIA, culminating in several years as a member of the CIA's Senior Intelligence Service. From 2004 through 2007 he served as Chief of Station in a strategic country in the Middle East in one of the most senior assignments in the Near East Division. He managed a multi-million dollar budget, strategic programs, personnel, and families in high threat environment. His experience includes representing the CIA at the highest levels in foreign countries, the U.S. Executive Branch, the U.S. Congress, U.S. Military, on all intelligence and policy matters concerning the agency's operations. In 2002 he was selected by the Director of Central Intelligence as the senior executive and operational manager to lead the Agency's global effort to neutralize Al-Qaida. In that role, he interacted at the highest levels of the U.S Government, including the White House, FBI, Homeland Security, NSA, Congress, and various branches of the U.S. Military, on a daily basis. During this specific period the lion's share of the perpetrators of 9/11 were nullified.

    Visit the conference page to learn more:

    http://www.investorideas.com/Conference

    Presenting Companies at the Conference :

    American Public University System (NASDAQ:APEI) - Dr. Clay Wilson is the Program Director for Cybersecurity

    Dr. Clay Wilson is the Program Director for Cybersecurity graduate studies at the American Public University, where he has responsibility for designing new courses. He is past Program Director for Cybersecurity Policy at the University of Maryland University College (UMUC), where he oversaw development of new graduate-level courses. Dr. Wilson is also a former analyst for national defense policy at the Congressional Research Service where he analyzed cyber intelligence reports for the U.S. Congress and NATO committees on net-centric warfare, cybersecurity, nanotechnology, and other vulnerabilities of high-technology military systems and critical infrastructures. More info: www.apu.apus.edu/academic/faculty-member...

    About American Public University System (NASDAQ:APEI) American Public University System, winner of the Sloan Consortium's Ralph E. Gomory Award for Quality Online Education and first three-time recipient of Sloan's Effective Practice Award, offers more than 90 online degree programs through American Public University and American Military University. APUS's relevant curriculum, affordability and flexibility help more than 100,000 working adults worldwide pursue degrees in a diverse variety of subjects. For further information, visit apus.edu. http://www.apus.edu/about-us/facts.htm

    NXT- ID Inc. - Mobile Security for a Mobile World

    NXT-ID, Inc.'s (OTCQB:NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. www.thewocket.com/, www.wocketwallet.com/

    NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/ , http://3d-id.net/

    Tekcapital, Ltd. - The World's Largest University Network for Open Innovation. Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.

    PositiveID Corporation (OTCBB:PSID) develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays.

    Viscount Systems (OTCQB:VSYS), a Canadian manufacturer of advanced physical access control systems combines traditional access control performance with cyber security (true convergence of logical and physical access) to increase security while driving down facility costs to secure offices, hospitals, critical infrastructure, schools, banks, and manufacturing. Our unique offering satisfies new US Federal Government standards for increased protection of facilities from external threats. http://viscount.com/

    Implant Sciences (OTCQB:IMSC) is the leader in next generation Explosives Trace Detection (ETD), and established counter-terrorism technology that detects and identifies threats from the small amounts left behind after a person handles explosives. Implant Sciences' security solutions are used worldwide for aviation, public transport, customs, air cargo, critical infrastructure, ports/ borders, and emergency response. The Company has thousands of units deployed to over 50 countries, and its trace detectors have been successfully used at the Sochi Olympics, Beijing Olympics, the Universiade Games, and the Special Olympics.

    In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. With advanced capabilities including superior sensitivity, automatic internal calibration, rapid clear-down, ush button maintenance, and administration of trace detection. Company's handheld QS-H150 and desktop QS-B220 simplify the use, maintenance, and administration of trace detection. www.implantsciences.com

    Silanis Technology: Businesses and government organizations of all sizes choose Silanis Technology when electronic signatures matter. With more than 600 million documents processed every year, Silanis eSignLive™ is the most widely used esignaturesolution around the world. Thousands of organizations, big and small, including the leading banks, insurers, credit providers, pharmaceutical and government agencies trust eSignLive as their platform to make business digital. Silanis has been providing secure electronic signature solutions to government for over 15 years, and understands the unique security and signing needs of Federal DoD and civilian agencies, as well as state and local governments. Siilanis stands behind the longest running implementation of esignatures in the US government, and the largest signature initiative ever undertaken in government. Organizations that have standardized on Silanis include the US Joint Chiefs of Staff; the US Army with an enterprise license for 1.6 million personnel; and the General Services Administration (GSA), which mandated the use of esignatures for GSA Schedules contracts. www.silanis.com

    About InvestorIdeas.com: www.investorideas.com

    InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.

    Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country

    Contact info:

    Cali Van Zant cvanzant@investorideas.com 800. 665. 0411

    D. Van Zant dvanzant@investorideas.com 800. 665. 0411

    800-665-0411 - Source: www.Investorideas.com

     

    Mar 28 11:57 AM | Link | Comment!
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.